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DIETARY  THERAPY  IMPACT  FOR  CIRRHOTIC  PATIENTS  WITH  HEPATIC
ENCEPHALOPATHY (Abstract): BACKGROUND: Malnutrition is prevalent in all forms of
liver disease and it is associated with increased number of complications and increased short and
long  term  mortality.  AIM:  to  evaluate  the  level  of  serum  ammonia,  recurrence  of  hepatic
encephalopathy (HE), improvement of mental status and of the nutritional status after one month
of high protein high calorie (HPHC) diet the effect of a dietary therapy on cirrhotic patients with
HE.  MATERIALS  AND  METHODS:  Our  study  was  designed  as  a  descriptive  prospective
analysis of patients with cirrhosis and a previous episode of HE, admitted in Gastroenterology
Department of Elias Emergency Hospital, during one  year (January 2010-January 2011). The
diagnosis  of  cirrhosis  was  based  on  the  medical  history, physical  examination,  biochemical
findings and imagistic  methods. It  was evaluated  mental  status, serum level of ammonia and
nutritional parameters, before and after one month diet. RESULTS: A significant decrease in the
blood ammonia levels was observed. A significant number of patients showed an improvement of
their mental status assessed by West Haven scale after diet. A significant improvement of number
connection test (NCT) scores was also noted. Body weight was slightly but significantly increased
after a month of diet. Mid-arm muscle circumference (MAMC) increased after one month diet,
but not statistically significant. CONCLUSIONS: The HPHC diet has a beneficial effect on the
patients with cirrhosis and hepatic encephalopathy, more significant regarding the mental status,
level of the serum ammonia and the body  weight. It  was noted an improvement of  mid arm
muscle circumference. Key words: hepatic encephalopathy, diet, malnutrition, liver cirrhosis.
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INTRODUCTION
Malnutrition has a high prevalence in
all forms of liver disease, ranging from 20%
in  compensated  liver  disease  to  more  than
80%  in  those  patients  with  decompensated
liver  disease  and  100%  in  hospitalized
patients  with  acute  alcoholic  hepatitis
superimposed on cirrhosis [1]. Patients with
alcoholic cirrhosis have a higher incidence
of malnutrition than those with nonalcoholic
liver disease.
Protein-calorie  malnutrition  (PCM)
can be identified in all clinical stages, but is
easier observed in advanced stages of liver
disease [2].
There  are  a  number  of  factors  that
contribute  to  malnutrition  in  patient  with
liver  disease  such  as  decreased  calories374 Teiuşanu A. et al.
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intake,  decreased  nutrients  absorption  or
impaired metabolic absorption [3].
Many descriptive studies have shown
higher rates of complications and mortality
in  cirrhotic  patients  with  protein
malnutrition  as  well  as  reduced  survival
when  such  patients undergo  liver
transplantation [4].
Hepatic  encephalopathy  (HE)  is  a
neuropsychiatric  condition  that  leads  to
mental  status  changes  and  abnormal
neuromuscular  function  in  patients  with
acute and chronic liver failure [5].
More than 35% of hospitalizations are
related to HE, with lengths of stay between 5
and 7 days [6].
Two  forms  of  HE  are  recognized:
minimal hepatic encephalopathy (MHE) and
overt  hepatic  encephalopathy  (OHE).
Patients  with  MHE  have  no  clinical
symptoms  of  HE,  but  subtle  deficits  in
cognitive  function  that  can  be  detected  by
psychometric  or  neurophysiologic  testing.
OHE is characterized by symptoms ranging
from  trivial  lack  of  awareness  to  loss  of
consciousness, and is usually assessed using
the West-Haven grading system [7].
Multiple recent studies have shown the
importance  of  maintaining  the  positive
nitrogen  balance  via  increased  protein  and
caloric  intake  in  cirrhotic  patients [5].
Negative  nitrogen  balance  due  to  protein
restriction  leads  to  protein-calorie
malnutrition  (PCM) [8],  and decrease  the
survival rate in patients with liver cirrhosis
[5].
The end point was to evaluate the level
of  serum  ammonia,  recurrence  of  HE,
improvement  of  mental  status  and  the
nutritional  status  in  patients  with  liver
cirrhosis before and after 1 month of high
protein high calories diet.
MATERIALS AND METHODS
Our  study  was  designed  as  a
descriptive  prospective  analysis  of  patients
with cirrhosis and a previous episode of HE,
admitted  in  Elias  Emergency  Hospital,
Gastroenterology  Department,  during  one
year (January 2010-January 2011).
Inclusion  criteria  were:  age  between
18 and 80 years, documented liver cirrhosis
in  a  stable  hemodynamic  condition,
compliance to dietary recommendations and
medical treatment, with a previous episode
of HE.
Exclusion criteria were: overt hepatic
encephalopathy (OHE) stage III or IV (West
Haven  criteria),  active  gastrointestinal
bleeding,  ongoing  alcoholism,  sepsis,  liver
failure,  hepatocellular  carcinoma  or  other
known malignancies.
The diagnosis of cirrhosis was based
on  the  medical  history,  physical
examination,  biochemical  findings  and
imagistic  methods  (ultrasound  and/or
computed tomography).
Assessment  of  the  mental  status  was
performed  using  West  Haven  scale.  Those
who  were  with  no  abnormalities  detected
(stage  0)  had  to  perform  a  conventional
Number  Connection  Test  (NCT),  using
circles  numbered  from  1  to  25,  used  for
psychometric performance evaluation.
Laboratory  tests  included  cell  blood
count  (CBC),  bilirubin,  albumin,
prothrombin  time  (PT),  serum  ammonium,
International Normalized Ratio (INR), urea,
creatinine,  which  were  used  to  calculate
Child  Pugh  score  and  to  laboratory
evaluation;  all  markers  were  measured  by
standard laboratory methods.
In  order  to  evaluate  the  nutritional
status of the patients with cirrhosis we used
mid-arm  muscle  circumference  (MAMC)
[9,10],  an anthropometric  parameter  were
that is not affected by the presence of ascites
or peripheral edema and body weight.
Patients  from  this  study  received
medical  treatment  including  lactulose  in
order  to obtain  2-3  semisolid  stools  daily
and rifaximin 1200 mg/day.
They  were  followed  for  1  month.
During that period they received high caloric
high  protein  (HPHC)  diet:  30kcal/kg/day
and  1.2g  of  proteins/kg/day.  They  were
allowed to eat only 100g of poultry meat or
fish twice a week. The proteins were from
vegetables,  cereals  or  milk  products,
approximately 20-25% vegetables and fruits,Hepatic encephalopathy: dietary therapy 375
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25-30% cereals and 45-50% milk and milk
products. The feeding pattern was designed
to provide 4 meals during the day and a late-
night snack rich in carbohydrates at 10 p.m.
They  were  asked  to  choose  from  a  menu
with  several  alternatives  by  individual
preference  and  tolerance.  The  tolerance  of
the  cirrhotic  patients  to  dietary
recommendation  was  excellent;  no  one
withdrew from this study because of lack of
compliance.
The  protocol  conformed to  the
Declaration of Helsinki and Guidelines for
Good Clinical Practice in Clinical Trials and
was  approved  by  the  Elias  Emergency
Hospital Committee. All patients signed an
informed consent.
A descriptive study of the quantitative
values  was  undertaken by  using  mean  and
standard  deviation  values,  and  qualitative
values were expressed as frequencies.
RESULTS
A  series  of  68  hospitalized  patients
with cirrhosis, 43 male (63%) and 25 female
(37%), was included, the median age was 54
(range 30-68).
The etiology  of  liver  disease  was
alcoholic in 26 patients (38%), viral-related:
B,  C,  B+D,  B+C  in  24  (35%),  mixed:
alcohol + viral  in  13  patients  (19%)  and
other  etiologies  (autoimmune,  primary
biliary  cirrhosis,  cryptogenic)  in  5  patients
(8%).
The  degree  of liver  disease  was
assessed using the Child Pugh classification.
Liver function was relatively well preserved
(Child A) in 19 patients (28%), moderately
compromised (Child B) in 46 patients (67%)
and  severely  compromised  (Child  C)  in  3
patients (5%).
Clinical  examination  included  the
evaluation  of  the  presence  of  ascites  and
edema.  53  patients  (77%)  had  ascites,  as
followed:  33  patients  with  slight  ascites
(63%) and 20 with moderate ascites (37%),
and 15 patients (23%) didn’t have. Only 9
patients had edema (13%).
From  all  that  patients  (28)  only  10
patients  had  abnormal  NCT  (36%),
corresponding  to  minimal  hepatic
encephalopathy (MHE).
A  significant  decrease  in  the  blood
ammonia levels was observed after a month
of HPHC diet, when all patients included in
the study were considered. The decrease in
blood  ammonia  level  was  observed  in  all
patients as it is revealed in Table I.
Table I The ammonia level and NCT scores before
and after HPHC diet
Before
diet
(mean)
After
diet
(mean)
P value
Blood ammonia * 58.3 35.2 <0.0001
NCT scores 62 52 <0.0001
* normal range: 11-33 µmol/L
No  patient  was  withdrawn  from  the
study due to a recurrent episode of HE. A
significant  number  of  patients  showed  an
improvement  of  their  mental  status  after
diet: 45% from stage I patients (West Haven
scale) meaning 10 patients became stage 0.
Fourteen  patients  with  stage  II  (75%)
became stage I and only 4 (25%) from 18
patients remained in stage II (Table II).
Table II Evolution of the mental status according to
the initial stage of HE assessed by West Haven scale.
No improvement
(%)
1 stage
improvement
(%)
Initial  West
Haven stage I 12 (55) 10 (45)
Initial  West
Haven stage II 4 (25) 14 (75)
That means, after a month of diet, the
classification  of  the  patients  contains:  38
patients  (56%)  with  stage  0,  26  patients
(38%) stage I and only 4 (6%) with stage II.
None of these patients worsened the mental
status.
The  repartition  of  different  stages,
before  and  after  the  diet,  is  revealed in
Table III.
A significant improvement of number
connection test (NCT) scores was also noted376 Teiuşanu A. et al.
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when the initial scores were compared with
the scores obtained after a month of HPHC
diet.
Taking  into  account  the  severity  of
liver disease, 63% of patients (29 patients) in
Child  B  stage  had  an  improvement  in  the
grade of HE, compared with only one patient
(33%) with Child C cirrhosis.
Table III Global repartition of different West Haven
stages, before and after the diet
No of patients Stage 0 Stage I Stage II
Before diet 28 22 18
After diet 56 38 4
The improvement of HE after the diet
was not as good in patients with alcoholic
cirrhosis as in patients with viral or mixed
etiology. 35% of alcoholic patients improved
their  mental  status  after  HPHC  diet,
compared  with  43%  of  patients  with  viral
etiology  and  with  46%  of  patients  with
mixed  etiology,  but  this  difference  didn’t
reach statistical significance (P=0.06).
Body  weight  was  slightly  but
significantly increased after a month of diet.
Mean  value  before  diet  was  68.3  kg  and
after the HPHC diet reached up to 69.2 kg
(P =0.008). Mid-arm muscle circumference
(MAMC) increased from 28.6 cm to 29.3 cm
after  one  month  diet,  but  not  statistically
significant.
DISCUSSION
Hepatic  encephalopathy  (HE)  is  a
neuropsychiatric  condition  of  impaired
mental  status  and  abnormal  neuromuscular
function  that  may  occur  in  patients  with
advanced  liver  disease  and  has  a  potential
for full reversibility [8].
Minimal  hepatic  encephalopathy
(MHE)  has  no  recognizable  clinical
symptoms.  It  is  present  in  30-84%  of
patients with liver cirrhosis. It is diagnosed
by neuropsychological tests.
Hepatocellular  failure,  portosystemic
shunting,  sepsis,  variceal  bleeding,  excess
dietary  intake  or  electrolyte  imbalance  are
the most common precipitating factors that
contribute to develop of HE [8].
European  Society  for  Clinical
Nutrition  and  Metabolism  (ESPEN)
recommends that patients with liver cirrhosis
should receive 35-40 kcal/kg per day [11].
Protein requirements  are  increased  in
cirrhotic patients and high protein diets are
generally  well  tolerated  in  the  majority  of
patients.
The  inclusion  of  adequate  protein  in
the  diets  of  malnourished  patients  is  often
associated with a sustained improvement in
their  mental  status.  Protein  helps  preserve
lean  body  mass;  skeletal  muscle  makes  a
significant  contribution  to  ammonia
removal. Protein restriction must be avoided
and the recommendation is to maintain 1.2-
1.5 g proteins/kg/day [12].
In  severely  protein-intolerant  patients
it  is  recommended  branched-chain  amino
acids  (BCAA)  supplementation.  These
amino acids (leucine, isoleucine and valine)
cannot be synthetized de novo.
Chronic liver disease is characterized
by a decrease in the serum level of BCAA,
whereas  hyperammonemia  increases  their
utilization [13].
The Fischer ratio, the balance between
branched-chain  amino  acids  (BCAA)  and
aromatic  amino  acids  (AAA),  is  3:1  in
healthy  population.  It  becomes  inverted  in
cirrhotic  patients.  BCAA  are  essential  for
protein  production  and  prevent  the
catabolism. AAA are precursors for “false”
neurotransmitters  such  as  octopamine  and
phenylethylamine,  contributing  to
neurologic dysfunction [13].
A  meta-analysis  of  BCAA
supplementation revealed the improved rate
of recovery from episodic HE, but did not
demonstrate a survival advantage [14].
Long-term  oral  supplementation  with
BCAA mixture is better than ordinary food
to improve the serum albumin level and the
energy metabolism in cirrhotic patients [15].
In the same study body weight was slightly
but significant increase in the BCAA group.
A  significant  correlation  was
established  with  midarm  muscleHepatic encephalopathy: dietary therapy 377
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circumference (MAMC), but not with triceps
skinfold thickness (TST).
In  a  randomized,  double-blind,
multicenter study, comparing a supplement
of  BCAA  or  maltodextrin  the  conclusions
were that the supplementation with BCAA
after  an  episode  of  HE  does  not  decrease
recurrence of HE. BCAA improve minimal
HE and muscle mass [16].
The timing of BCAA supplementation
may be crucial. This issue was addressed by
a crossover study. At 3 months, a significant
increase  in  serum  albumin  level  was
observed in patients administered nocturnal
BCAA.
It leads to an increase of serum protein
of  approximately  10%  if  given  before
bedtime [17]. Problems that limit the use of
BCAA in the treatment of HE are their taste
and expense.
Our  study  shows  that  protein  and
energy  requirements  for  cirrhotic  patients
may be maintained in patients with HE. It
leads  to  improvement  of  mental  status  in
90% of patients. Our study confirms recent
studies showing that patients tolerate high-
protein diets and benefit of them.
Most  patients  tolerate  HPHC  diet
without risk of HE. It improves mental status
in a significant way. A higher proportion of
patients  with  severe  impairment  of  the
mental status improved after one month diet
(63%). A lower proportion of patients with
alcoholic  cirrhosis  improved  their  mental
status  compared  with  those  with  viral  or
mixed etiology. A significant improvement
of number connection test (NCT) scores was
also noted after the diet.
A  decrease  in  blood  ammonia  level
was  noted  not  only  for  patients  with
improvement of mental status, but also for
the  patients  that  maintained  their  mental
status.  No  one  had  an  increase  of  serum
level  ammonia.  This  HPHC  diet  had  a
significant improvement on the body weight
and  mid  arm  muscle  circumference
(MAMC) after a month of treatment.
We  used  an  eating  schedule
characterized by 4 meals during the daytime
a  a  late  evening  snack  consisting  in  food
reach in carbohydrates. Like similar studies
that referred to reach in BCAA late evening
snacks  diets,  this  study  shows  a  better
outcome  from  the  mental  status  and
nutritional point of view.
CONCLUSION
High  protein  high  calorie  diet  had  a
beneficial  effect  on  the patients  with
cirrhosis  and  hepatic  encephalopathy.  This
effect was statistically significant regarding
the  mental  status,  level  of  the  serum
ammonia and the body weight.
The daily eating pattern consisting in 4
meals and l late evening snack contributed to
HE  improvement,  avoiding  protein  loading
in  a  period  of  day,  but  maintaining  the
protein positive balance.
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